Masimo (MASI) Competitors $152.06 -1.55 (-1.01%) Closing price 04:00 PM EasternExtended Trading$149.30 -2.76 (-1.81%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. RMD, IDXX, DXCM, STE, PODD, BAX, HOLX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "health care equipment" industry. Masimo vs. ResMed IDEXX Laboratories DexCom STERIS Insulet Baxter International Hologic Globus Medical Teleflex Integer ResMed (NYSE:RMD) and Masimo (NASDAQ:MASI) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends. Does the media refer more to RMD or MASI? In the previous week, ResMed had 11 more articles in the media than Masimo. MarketBeat recorded 28 mentions for ResMed and 17 mentions for Masimo. ResMed's average media sentiment score of 1.50 beat Masimo's score of 1.19 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 23 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Masimo 13 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in RMD or MASI? 55.0% of ResMed shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 0.7% of ResMed shares are held by company insiders. Comparatively, 9.7% of Masimo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is RMD or MASI more profitable? ResMed has a net margin of 25.34% compared to Masimo's net margin of 3.85%. ResMed's return on equity of 26.17% beat Masimo's return on equity.Company Net Margins Return on Equity Return on Assets ResMed25.34% 26.17% 18.60% Masimo 3.85%14.98%6.95% Which has more risk and volatility, RMD or MASI? ResMed has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Which has better earnings and valuation, RMD or MASI? ResMed has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioResMed$4.93B6.33$1.02B$8.4725.07Masimo$2.09B3.94$81.50M-$5.70-26.78 Does the MarketBeat Community prefer RMD or MASI? Masimo received 32 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 63.79% of users gave Masimo an outperform vote while only 52.74% of users gave ResMed an outperform vote. CompanyUnderperformOutperformResMedOutperform Votes43352.74% Underperform Votes38847.26% MasimoOutperform Votes46563.79% Underperform Votes26436.21% Do analysts rate RMD or MASI? ResMed currently has a consensus price target of $249.73, indicating a potential upside of 17.60%. Masimo has a consensus price target of $194.80, indicating a potential upside of 27.61%. Given Masimo's stronger consensus rating and higher probable upside, analysts plainly believe Masimo is more favorable than ResMed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ResMed 1 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.67Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 SummaryResMed beats Masimo on 11 of the 19 factors compared between the two stocks. Remove Ads Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.25B$3.11B$5.32B$7.60BDividend YieldN/A1.81%5.11%4.33%P/E Ratio105.2814.4421.7517.84Price / Sales3.9444.79378.5093.37Price / Cash30.7444.0938.1534.64Price / Book5.923.316.444.01Net Income$81.50M$94.03M$3.20B$247.23M7 Day Performance5.23%6.46%6.58%7.44%1 Month Performance-9.25%-7.64%-8.54%-6.13%1 Year Performance10.53%-21.35%10.13%-0.02% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.3933 of 5 stars$152.06-1.0%$194.80+28.1%+11.4%$8.22B$2.09B104.876,200RMDResMed4.4119 of 5 stars$213.06+3.8%$249.73+17.2%+15.4%$31.29B$4.93B25.158,160Analyst RevisionPositive NewsGap DownHigh Trading VolumeIDXXIDEXX Laboratories4.8008 of 5 stars$378.99-3.7%$533.75+40.8%-18.7%$30.71B$3.90B35.5210,800Analyst DowngradePositive NewsHigh Trading VolumeDXCMDexCom4.9089 of 5 stars$61.63+3.0%$99.82+62.0%-50.5%$24.17B$4.03B43.107,600Positive NewsHigh Trading VolumeSTESTERIS4.6048 of 5 stars$212.62+0.0%$258.75+21.7%+9.9%$20.89B$5.40B45.1416,000Positive NewsPODDInsulet4.5775 of 5 stars$256.23+4.5%$292.06+14.0%+45.8%$17.99B$2.07B44.252,600Short Interest ↓Positive NewsBAXBaxter International4.5611 of 5 stars$28.61-0.6%$38.56+34.8%-29.8%$14.67B$10.64B-22.3560,000HOLXHologic4.8249 of 5 stars$61.27+0.7%$84.62+38.1%-23.9%$13.75B$4.04B19.336,940Positive NewsHigh Trading VolumeGMEDGlobus Medical4.7597 of 5 stars$70.74+2.8%$97.09+37.2%+41.3%$9.73B$2.52B94.322,600Short Interest ↑News CoveragePositive NewsGap DownTFXTeleflex4.4012 of 5 stars$130.95-0.7%$182.63+39.5%-38.4%$6.07B$3.05B26.0315,500High Trading VolumeITGRInteger3.0651 of 5 stars$112.79-0.8%$148.56+31.7%+2.0%$3.79B$1.72B33.5710,500High Trading Volume Remove Ads Related Companies and Tools Related Companies ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MASI Stock Free MASI Stock Alerts